— Know what they know.
Not Investment Advice

688331.SS SHH

RemeGen Co. Ltd. Class A
1W: -6.2% 1M: -3.6% 3M: -16.4% YTD: +10.0% 1Y: +87.4% 3Y: +78.5%
¥117.34 ($17.50)
+0.67 (+0.57%)
 
SHH · Healthcare · Biotechnology · Tech Score Sell · Power 42 · ¥64.9B mcap · 463M float · 1.99% daily turnover

Cash Flow Trends

Operating Cash Flow
$56M +104.8% ▲
Capital Expenditures
$200M +24.4% ▲
5Y CAGR: -16.1%
Free Cash Flow
-$144M +90.0% ▲
Dividends Paid
$0 +100.0% ▲
Buybacks
$43M -53.6% ▼
Net Change in Cash
$435M +1219.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$276M-$999M-$1.5B-$1.5B$709M
Depreciation & Amort.$120M$186M$241M$303M$0
Stock-Based Comp.$19M$56M$86M$0$0
Change in Working Capital-$168M-$524M-$361M-$169M-$444M
Other Non-Cash Items$16M$17M$44M$159M-$208M
Operating Cash Flow$264M-$1.3B-$1.5B-$1.2B$56M
— Investing Activities —
Capital Expenditures-$615M-$756M-$853M-$265M$0
Acquisitions (Net)$0-$2M-$1M$7M$0
Investment Purchases$0-$1.9B-$1.0B-$1.0B$0
Investment Sales$0$1.8B$968M$1.0B$0
Other Investing-$23M-$27M$107M$62M-$209M
Investing Cash Flow-$638M-$842M-$818M-$186M-$209M
— Financing Activities —
Net Debt Issuance-$108M-$59M$1.1B$1.5B$141M
Stock Repurchased$0$0$0-$28M-$43M
Dividends Paid$0$0-$15M-$70M$0
Other Financing-$70M-$86M-$67M-$56M$453M
Financing Cash Flow-$627M$2.4B$978M$1.4B$552M
Net Change in Cash-$1.0B$312M-$1.3B$33M$435M
Cash End of Period$1.8B$2.1B$727M$760M$1.2B
Free Cash Flow-$354M-$2.0B-$2.4B-$1.4B-$144M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms